January 8, 2014

News stories about doctor shopping and prescription pad pilfering in pursuit of a pain-pill induced high have become commonplace, prompting many legislators and regulators to consider further restrictions on pain medicines like hydrocodone compounds. But there may be a story that’s not being told — that the patients who suffer from chronic pain and need that hydrocodone to reclaim their lives are being stigmatized. The prevalence of pain pill abuse has left in its wake as many as 116 million legitimate pain sufferers who are finding it more difficult to access their therapies.

February 27, 2015

Camber Pharmaceuticals' latest generic drug launch is used to treat pulmonary hypertension.

February 27, 2015

Epic Pharma on Friday launched two generics: a schedule II pain reliever and a calcium channel blocker. 

February 26, 2015

A survey found that chronic disease patients who use digital technology to manage their disease state feel "healthier."

 

February 26, 2015

The fixed-combination drug Avycaz was granted priority review by the Food and Drug Administration. 

February 26, 2015

Greenstone, a subsidiary of Pfizer, announced the introduction of trandolapril/verapamil hydrochloride extended-release tablets to its line of generic pharmaceutical products. 

 

February 25, 2015

GlaxoSmithKline's Alli weight loss aid is making a return to shelves.

February 25, 2015

In 10 years, the percentage of opioid analgesic users who used an opioid analgesic stronger than morphine increased from 17% to 37%, NCHS reported Wednesday. 

February 24, 2015

Irish Spring unveils new signature line for men and develops an interactive tool so guys can analyze their signatures.

February 20, 2015

Actavis on Friday gained approval for a generic version of Reckitt Benckiser's Subutex, indicated for the treatment of opioid dependence.

February 19, 2015

Multicultural beauty brand Black Opal launches new multimedia campaign to inspire and engage women of all complexions.

February 17, 2015

Teva Pharmaceuticals on Tuesday announced the launch of generic versions of Lovenox (enoxaparin sodium injection) as well as generic Zyvox (linezolid) injection. 

 

February 12, 2015

Sandoz on Thursday launched telmisartan tablets, the generic version of Micardis from Boehringer Ingelheim. The drug is used to treat hypertension, the company said.

 

February 11, 2015

Sam's Club will be showing its love to its customers this Valentine's Day with the offering of a free heart health screening.

February 9, 2015

Daiichi Sankyo on Monday announced that its Savaysa (edoxaban) tablets are now available in pharmacies across the United States. The drug was granted approval from the Food and Drug Administration on Jan. 8 and is used to reduce the risk of stroke and systemic embolism in patients who have a non-valvular atrial fibrillation, as well as for the treatment of deep vein thrombosis and pulmonary embolism, the company said.

February 9, 2015

Mylan Inc. and its subsidiary Mylan Pharmaceuticals are being sued by Bayer Healthcare, Bayer Healthcare Pharmaceuticals and Onyx Pharamceuticals in relation to the filing of an abbreviated new drug application for sorafenib tablets, the generic version of Nexavar. 

 

February 6, 2015

There is a sharp spike in cough-cold promotion across retail circulars in the back-to-school season, according to an analysis of circular retail promotions provided by ECRM, as moms prepare their families for the inevitable season of sniffles and sneezes with the coming school year. 

 

February 6, 2015

Prestige Brands will be resuming healthcare professional marketing programs in support of its Monistat vaginal treatments.

February 5, 2015

There is a sharp spike in cough-cold promotion across retail circulars in the back-to-school season, according to an analysis of circular retail promotions provided by ECRM, as moms prepare their families for the inevitable season of sniffles and sneezes with the coming school year.

February 5, 2015

Merck earlier this week announced that Belsomra (suvorexant) is now available at pharmacies in the United States for the treatment of insomnia.

February 4, 2015

Procter & Gamble’s Gillette is promising a rust-free bathroom with its new Gillette Fusion ProGlide Sensitive 2-in-1 Shave Gel Plus Skin Care.

February 3, 2015

Teva Pharmaceuticals on Tuesday announced the introduction of dexmethylphenidate hydrochloride extended-release capsules, CII, in 10-mg dosage strength.

February 3, 2015

Zogenix last week announced that the Food and Drug Administration approved a new formulation of the company's Zohydro ER (hydrocodone bitartrate) extended-release capsules, CII.

January 30, 2015

Janssen Therapeutics on Thursday announced that the Food and Drug Administration has approved its Prezcobix (darunavir 800 mg/cobicistat 150 mg) tablets. The drug is used to treat human immunodeficiency virus in combination with other antiretovirals for treatment-naïve and treatment-experienced adults with no darunavir resistance-associated substitutions, according to the company.